IFNG and cancer: Recent studies on oropharyngeal squamous cell carcinoma have revealed that the downregulation of CD161 can lead to the immune escape of cancer cells [31], while IL-17 and IFN-γ produced by CD161+ T cells can reduce tumor burden and improve OS [32].